CIK 0001133869 · Non-accelerated filer<br>Smaller reporting company
CAPRICOR THERAPEUTICS, INC.
Sign in to watch- Ticker
- CAPR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (310) 358-3200
- Business address
- 10865 ROAD TO THE CURE, SUITE 150, SAN DIEGO, CA, 92121
- Former names
- Nile Therapeutics, Inc., SMI PRODUCTS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2009-07-07 | Evans Daron Chief Financial Officer | Purchase | +3,952 | 14,152 | ||
| 2009-07-07 | Evans Daron Chief Financial Officer | Purchase · Warrant (Right to Buy) | +988 | 988 | ||
| 2009-07-07 | Evans Daron Chief Financial Officer | Purchase · Warrant (Right to Buy) | +988 | 988 | ||
| 2009-07-07 | Evans Daron Chief Financial Officer | Purchase · Warrant (Right to Buy) | +1,976 | 1,976 | ||
| 2009-07-07 | KASH PETER M Director | Purchase | +98,814 | 1,596,208 | ||
| 2009-07-07 | KASH PETER M Director | Purchase · Warrant (Right to Buy) | +24,704 | 24,704 | ||
| 2009-07-07 | KASH PETER M Director | Purchase · Warrant (Right to Buy) | +24,703 | 24,703 | ||
| 2009-07-07 | KASH PETER M Director | Purchase · Warrant (Right to Buy) | +49,407 | 49,407 | ||
| 2009-07-07 | Kazam Joshua A Director | Purchase | +197,628 | 1,278,228 | ||
| 2009-07-07 | Kazam Joshua A Director | Purchase · Warrant (Right to Buy) | +49,407 | 49,407 | ||
| 2009-07-07 | Kazam Joshua A Director | Purchase · Warrant (Right to Buy) | +49,407 | 49,407 | ||
| 2009-07-07 | Kazam Joshua A Director | Purchase · Warrant (Right to Buy) | +98,814 | 98,814 | ||
| 2009-06-24 | Evans Daron Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2009-03-13 | Evans Daron Chief Financial Officer | Purchase | +5,000 | $0.75 | $4K | 9,200 |
| 2009-03-12 | Kazam Joshua A Director | Purchase | +510 | $0.75 | $383 | 1,080,600 |
| 2009-03-11 | Evans Daron Chief Financial Officer | Purchase | +6,000 | $0.77 | $5K | 10,200 |
| 2009-01-16 | Evans Daron Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +49,020 | 49,020 | ||
| 2009-01-16 | Evans Daron Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +43,269 | 43,269 | ||
| 2009-01-16 | Lieu Hsiao VP, Clinical Research | Grant or award · Stock Option (Right to Buy) | +9,123 | 9,123 | ||
| 2009-01-16 | Lieu Hsiao VP, Clinical Research | Grant or award · Stock Option (Right to Buy) | +31,003 | 31,003 |
Page 28 of 31 · 605 trades